Tag: FAS Russia

Federal Antimonopoly Service (the FAS Russia) is an authorized federal executive body, which is carrying out its functions with regard to the approval of the regulatory legal acts and control over compliance with the antimonopoly legislation, legislation in the field of natural monopolies’ activity, in the field of state regulation of prices (tariffs) for the goods (services), advertising, foreign investments in the business entities of strategic importance for the Russian national defence and state security, control in the field of state defence order, purchases of goods, works and services for the state and municipal needs and procurement of goods, works and services by certain legal entities, as well as with regard to the approval of closed methods for selection of suppliers (contractors, performers).

Improving Solutions in Healthcare in Russia

French-Russian Round Table “Partnership in the name of health. Improving solutions and provision in healthcare” was organized in Moscow. The event focused on assessment of healthcare technologies, dev...

Method of Price Registration in Russia

The state policy on medicine and medical products circulation was discussed at the XI All-Russian Congress of the Pharmaceutical and Medical Industries. “Unfortunately, current trend is to tie all ...

Russian Suppliers of Narcotic Tests Refused to Compete

Moscow OFAS exposed a cartel formed by the participants of 70 e-auctions for supplying tests for exposing narcotic agents. The total initial maximum contract price was over 115.3 million RUB. Two M...

Alexandra Feldman: The pharmaceutical market requires especially thorough control

The Working Group (BRICS+) on Pharmaceutics discussed pricing and state price regulation The 14th session of the International Working Group on studying competition on the pharmaceutical markets to...

N. Sharavskaya: Innovative medicine through a prism of the current law

Representatives of the pharmaceutical business and the authorities discussed the prospects for innovative medicine in the Russian markets Last week Moscow hosted the “Formula of the Future” I Natio...

T. Nizhegorodtsev: Possibilities of the pharmaceutical market depend on the national medical law

Timophei Nizhegorodtsev
Head of FAS Department for Control over Social Sphere and Trade discussed competition development in the pharmaceutical markets in Russia and the CIS Speaking at the workshop for staff of competiti...

“Novopharm” OJSC paid over 5 million rubs fine

FAS Russia
The company is punished for an anticompetitive agreement with “PHARM-SKD” Ltd. The 5,393,947.11 RUB fine is fully paid within the statutory period. The anticompetitive agreement was implemented ...

Medical Suppliers Cartel Detected in Novosibirsk

Novosibirsk OFAS found that “FITO” Ltd. and “Terra” Ltd. violated Clause 2 Part 1 Article 11 of the Federal Law “On Protection of Competition” The antimonopoly body established that in 2016-2017 “F...

Lack of Registered Med Does Not Help Competition in Russia

Representatives of the competition authorities of Russia and Belarus exchanged experiences of regulating pharmaceutical markets. At the Round Table on the “Common market of medicines. Reference pri...

Regulating Medicine Prices in Russia

On 26 February, representatives of FAS Department for Control over Social Sphere and Trade took part in a meeting of the Healthcare Committee at Franco-Russian Chamber of Commerce. Due to the recent c...

Keeping Competition on Russian Pharma Market

Stats-Secretary, Deputy Head of FAS Andrey Tsarikovskiy discussed specifics of state regulation of the medicine market and Russian experience in this field On 28 February 2019, Minsk (Belarus) host...

Monopoly Signs on Pharma Equipment Market Eliminated in Russia

The Federal Service for Healthcare Supervision executed FAS warning to stop actions (omissions) that contained signs of violating the antimonopoly law. As informed earlier, re-registering pharmaceu...

Overprised Medicine Detected in Russia

On 13 March 2019, the Prosecutor’s Office of Yakutia, the Ministry of Interior in the Sakha (Yakutia) Republic, and Yakutia OFAS carried out a joint inspection to check whether the law is observed in ...

Russian Companies are Fined for Anticompetitive Agreements

Vesta Pharm Ltd. and Pharm Project Ltd. are fined for an anticompetitive agreements with medical organizations who were ordering parties for medicinal supplies In accord with the agreement, the ord...

Importance of Introducing Forced Licensing in Russia

Head of FAS Department for Social Sphere and Trade was a speaker at the Gaidar Forum where he talked about the importance of introducing forced licensing. Many international experts and scholars unde...

Reference pricing in Russia corresponds best practices of price regulation

Speaking at OECD Competition Committee in Paris, Deputy Head of FAS discussed a set of FAS measures towards reducing the maximum ex-works manufacturer prices registered in Russia for medicine to the m...